LILLIE JAMES WOODRUFF (Chief Scientific Officer) sold 7.5% of their position (18.27K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $673.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Voting Common Stock
Shares
−2.24K
Price / share
$36.00
Trade value
$80.57K
% of position
Voting Common Stock
Shares
−5.39K
Price / share
$36.99
Trade value
$199.49K
% of position
Voting Common Stock
Shares
−12.00
Price / share
$37.54
Trade value
$450.48
% of position
Voting Common Stock
Shares
−5.01K
Price / share
$36.45
Trade value
$182.58K
% of position
Voting Common Stock
Shares
−3.53K
Price / share
$37.26
Trade value
$131.38K
% of position
Voting Common Stock
Shares
−12.00
Price / share
$37.96
Trade value
$455.52
% of position
Voting Common Stock
Shares
−2.08K
Price / share
$37.90
Trade value
$78.72K
% of position
Net shares
−18.27K
Net value
-$673.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −2.24K | $36.00 | $80.57K | 0.9% | 242.73K | 240.49K |
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −5.39K | $36.99 | $199.49K | 2.2% | 240.49K | 235.10K |
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −12.00 | $37.54 | $450.48 | 0.0% | 235.10K | 235.09K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −5.01K | $36.45 | $182.58K | 2.1% | 235.09K | 230.08K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −3.53K | $37.26 | $131.38K | 1.5% | 230.08K | 226.55K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −12.00 | $37.96 | $455.52 | 0.0% | 226.55K | 226.54K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −2.08K | $37.90 | $78.72K | 0.9% | 226.54K | 224.46K |
| Total | −18.27K | -$673.64K | ||||||